European Alliance for Personalised Medicine Inaugural Congress, Belfast
“Personalising your Health – a global imperative”
27th-30th November 2017
Over six hundred delegates attended the inaugural event from across EU member states and held in conjunction with the Estonian presidency. S:CORT professors Tim Maughan and Richard Sullivan and Lisa Wilde from BC-UK all took part in the acclaimed session; “left behind and burnt out? The lived experience of the molecularly unstratified patient and stratified medicine researchers.” During the session both S:CORT and FOCUS4 were given as exemplars of the progress in precision medicine research. Posters were also presented during breakout sessions representing our work in the fields of; patient and public involvement, health economics and tumour heterogeneity.
The event was also attended by policy makers, patient groups and industry representatives from across Europe helping to achieve the congress objective to put personalised medicine at the forefront of European decision making on health.
Through new research led by Queen’s University Belfast we have discovered how a genomic approach to understanding bowel (colorectal) cancer could improve the prognosis and quality of life for patients.
In a novel public engagement event designed to showcase the potential benefits of personalised cancer medicine, Almac Diagnostics, a leading personalised medicine company, opened its doors to cancer patients in Northern Ireland enabling them to see “Science in Action” and how partnerships between industry and academia have the potential to benefit patients suffering from the disease.
On January 13th 2016, the Consortium Management Group of S:CORT met at the University of Leeds. As part of our outreach strategy, a public engagement event “Stratified Medicine – Providing Hope for Cancer Patients” took place at the Thackray Medical Museum. Speakers included Alf Oliver who related his experiences as a bowel cancer survivor and Prof Mark Lawler (Public Engagement Lead) who gave a presentation entitled “Personalising Treatment for Cancer Patients”.